Younger donor’s age and upfront tandem are two independent prognostic factors of survival in multiple myeloma patients treated by tandem autologous-allogeneic stem cell transplantation: a retrospective study from the Societe' Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)